上海市通力律师事务所 关于科美诊断技术股份有限公司 2025 年第一次临时股东会的法律意见书 致:科美诊断技术股份有限公司 上海市通力律师事务所(以下简称"本所")接受科美诊断技术股份有限公司(以下简称 "公司")的委托,指派本所黄雅程律师、许宸律师(以下简称"本所律师")根据《中华人民 共和国公司法》《中华人民共和国证券法》《上市公司股东会规则》等法律法规和规范性文 件(以下统称"法律法规")及《科美诊断技术股份有限公司章程》(以下简称"公司章程") 的规定就公司 2025 年第一次临时股东会(以下简称"本次股东会")相关事宜出具法律意 见。 本所律师已经对公司提供的与本次股东会有关的法律文件及其他文件、资料予以了核 查、验证。在进行核查验证过程中,公司已向本所保证,公司提供予本所之文件中的所有签 署、盖章及印章都是真实的,所有作为正本提交给本所的文件都是真实、准确、完整和有效 的,且文件材料为副本或复印件的,其与原件一致和相符。 在本法律意见书中,本所仅对本次股东会召集和召开的程序、出席本次股东会人员资格 和召集人资格及表决程序、表决结果是否符合法律法规和公司章程的规定发表意见,并不对 本次股东会所审议的 ...

据证券之星公开数据整理，近期科美诊断（688468）发布2025年中报。根据财报显示，科美诊断净利润 同比下降68.24%。截至本报告期末，公司营业总收入1.65亿元，同比下降27.03%，归母净利润2434.08 万元，同比下降68.24%。按单季度数据看，第二季度营业总收入8331.53万元，同比下降27.04%，第二 季度归母净利润979.8万元，同比下降74.38%。 证券之星价投圈财报分析工具显示： 业务评价：公司去年的ROIC为7.54%，资本回报率一般。去年的净利率为29.13%，算上全部成本后， 公司产品或服务的附加值高。从历史年报数据统计来看，公司上市以来中位数ROIC为10.14%，投资回 报也较好，其中最惨年份2017年的ROIC为-135.16%，投资回报极差。公司历史上的财报相对一般 （注：公司上市时间不满10年，上市时间越长财务均分参考意义越大。），公司上市来已有年报3份， 亏损年份2次，显示生意模式比较脆弱。 偿债能力：公司现金资产非常健康。 商业模式：公司业绩主要依靠营销驱动。需要仔细研究这类驱动力背后的实际情况。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备31 ...

Core Insights - The company reported a significant decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its operational performance [1] Financial Performance - The company achieved a revenue of 165 million yuan, representing a year-on-year decrease of 27.03% [1] - The net profit attributable to shareholders was 24.34 million yuan, down 68.24% compared to the previous year [1] - The non-recurring net profit was 15.92 million yuan, reflecting a decline of 77.35% year-on-year [1] - Basic earnings per share stood at 0.06 yuan [1]

Group 1 - Hailiang Co., Ltd. achieved a revenue of 44.476 billion yuan, a year-on-year increase of 1.17%, and a net profit of 711 million yuan, a year-on-year increase of 15.03% [1] - Yinfai Storage reported a revenue of 543 million yuan, a year-on-year decrease of 18.97%, and a net profit of 62.347 million yuan, a year-on-year decrease of 20.05% [1] - Huamao Technology achieved a revenue of 1.108 billion yuan, a year-on-year increase of 14.42%, and a net profit of 137 million yuan, a year-on-year increase of 3.21% [2] Group 2 - Postal Savings Bank reported a revenue of 179.446 billion yuan, a year-on-year increase of 1.5%, and a net profit of 49.228 billion yuan, a year-on-year increase of 0.85% [4] - Bright Dairy achieved a revenue of 12.472 billion yuan, a year-on-year decrease of 1.9%, and a net profit of 217 million yuan, a year-on-year decrease of 22.53% [6] - Pianzaihuang reported a revenue of 5.379 billion yuan, a year-on-year decrease of 4.81%, and a net profit of 1.442 billion yuan, a year-on-year decrease of 16.22% [7] Group 3 - Great Wall Motors achieved a revenue of 92.335 billion yuan, a year-on-year increase of 0.99%, and a net profit of 6.337 billion yuan, a year-on-year decrease of 10.21% [9] - Haowei Group reported a revenue of 13.956 billion yuan, a year-on-year increase of 15.42%, and a net profit of 2.028 billion yuan, a year-on-year increase of 48.34% [10] - Batian Co., Ltd. achieved a revenue of 2.543 billion yuan, a year-on-year increase of 63.93%, and a net profit of 456 million yuan, a year-on-year increase of 203.71% [12] Group 4 - Yuxin Technology reported a revenue of 1.415 billion yuan, a year-on-year decrease of 5.01%, and a net profit of 220 million yuan, a year-on-year increase of 35.26% [14] - Zhongti Industry reported a revenue of 787 million yuan, a year-on-year decrease of 25.24%, and a net loss of 24.3955 million yuan [15] - Kemei Diagnostics achieved a revenue of 165 million yuan, a year-on-year decrease of 27.03%, and a net profit of 24.3408 million yuan, a year-on-year decrease of 68.24% [16] Group 5 - Huatai Co., Ltd. reported a revenue of 6.409 billion yuan, a year-on-year decrease of 1.86%, and a net profit of 67.6382 million yuan, a year-on-year decrease of 63.13% [17] - Fudan Fuhua reported a revenue of 326 million yuan, a year-on-year increase of 2.20%, and a net loss of 711.58 million yuan [19] - Haili Co., Ltd. achieved a revenue of 12.426 billion yuan, a year-on-year increase of 13.16%, and a net profit of 333.546 million yuan, a year-on-year increase of 693.76% [21] Group 6 - Xintong New Science reported a revenue of 61.852 million yuan, a year-on-year increase of 8.49%, and a net loss of 30.393 million yuan [22] - Newzhisoft achieved a revenue of 897 million yuan, a year-on-year decrease of 3.40%, and a net profit of 30.3531 million yuan, a year-on-year increase of 42.84% [24] - Maolai Optics reported a revenue of 319 million yuan, a year-on-year increase of 32.26%, and a net profit of 32.7555 million yuan, a year-on-year increase of 110.36% [25] Group 7 - Qianjin Pharmaceutical achieved a revenue of 1.818 billion yuan, a year-on-year decrease of 5.52%, and a net profit of 128 million yuan, a year-on-year increase of 8.50% [28] - Quanfeng Automotive reported a revenue of 1.218 billion yuan, a year-on-year increase of 18.90%, and a net loss of 167 million yuan [29] - Zhongjin Lingnan's application for a specific issuance of A-shares has been accepted by the Shenzhen Stock Exchange [31] Group 8 - Zhonglv Electric achieved a revenue of 2.333 billion yuan, a year-on-year increase of 29.30%, and a net profit of 618 million yuan, a year-on-year increase of 33.06% [33] - Sanhuan Group reported a revenue of 4.149 billion yuan, a year-on-year increase of 21.05%, and a net profit of 1.237 billion yuan, a year-on-year increase of 20.63% [35] - China Energy Construction achieved a revenue of 212.091 billion yuan, a year-on-year increase of 9.18%, and a net profit of 28.02 billion yuan, a year-on-year increase of 0.72% [37] Group 9 - Liou Co., Ltd. reported a revenue of 9.635 billion yuan, a year-on-year decrease of 9.62%, and a net profit of 478 million yuan, turning from a loss to profit [38] - Suzhou Bank achieved a revenue of 6.504 billion yuan, a year-on-year increase of 1.81%, and a net profit of 3.134 billion yuan, a year-on-year increase of 6.15% [40] - Shunxin Agriculture reported a revenue of 4.593 billion yuan, a year-on-year decrease of 19.24%, and a net profit of 173 million yuan, a year-on-year decrease of 59.09% [43] Group 10 - Tongfu Microelectronics achieved a revenue of 13.038 billion yuan, a year-on-year increase of 17.67%, and a net profit of 412 million yuan, a year-on-year increase of 27.72% [44] - Weidao Nano reported a revenue of 1.05 billion yuan, a year-on-year increase of 33.42%, and a net profit of 192 million yuan, a year-on-year increase of 348.95% [44] - ZTE Corporation achieved a revenue of 715.53 billion yuan, a year-on-year increase of 14.51%, and a net profit of 50.58 billion yuan, a year-on-year decrease of 11.77% [46]

科美诊断公告，2025年上半年营业收入1.65亿元，同比下降27.03%。净利润2434.08万元，同比下降 68.24%。 ...

科美诊断技术股份有限公司2025 年半年度报告 公司代码：688468 公司简称：科美诊断 科美诊断技术股份有限公司 2025 年半年度报告 1/168 科美诊断技术股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性，不 存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 重大风险提示 公司已在本报告中详细阐述公司在经营过程中可能面临的各种风险，敬请查阅本报告第三节 "管理层讨论与分析"中"风险因素"相关的内容。 三、 公司全体董事出席董事会会议。 四、 本半年度报告未经审计。 五、 公司负责人李临、主管会计工作负责人黄燕玲及会计机构负责人（会计主管人员）李进声 明：保证半年度报告中财务报告的真实、准确、完整。 六、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 □适用 √不适用 七、 是否存在公司治理特殊安排等重要事项 □适用 √不适用 八、 前瞻性陈述的风险声明 √适用 □不适用 本报告所涉及的公司未来计划、发展战略等前瞻性陈述，不构成公司对投资者的实质承诺， 请投资者注意投资风险。 九、 是否存在 ...

证券代码：688468 证券简称：科美诊断 公告编号：2025-017 科美诊断技术股份有限公司 2025 年半年度募集资金存放与使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 | 项目 | 金额 | | --- | --- | | 募集资金总额 | 293,150,000.00 | | 减：发行有关费用 | 44,593,051.99 | | 募集资金净额 | 248,556,948.01 | | 减：募集资金累计使用金额（包括置换先期投入金额） | 256,420,885.27 | | 其中：新建体外诊断试剂生产基地项目 | | | 123,143,353.57 | | --- | --- | --- | --- | | LiCA®试剂与配套仪器研发（实验室）项目 | | | 89,094,974.74 | | LiCA®试剂与关键生物原料研发项目 | | | 44,182,556.96 | | 减：支付发行费用的税金金额 | | | 2,128,301.88 | | 减：期末 ...

为深入贯彻党的二十大和中央金融工作会议精神，落实国务院《关于进一 步提高上市公司质量的意见》要求，积极响应上海证券交易所《关于开展沪市 公司"提质增效重回报"专项行动的倡议》，推动公司高质量发展和投资价值 提升，保护投资者尤其是中小投资者合法权益，科美诊断技术股份有限公司（ 以下简称"公司"）结合发展战略和实际经营情况制定了2025年度"提质增效 重回报"行动方案（以下简称"《行动方案》"），具体内容详见公司2025年 4月29日披露的《2024年度"提质增效重回报"行动方案的评估报告暨2025年 度"提质增效重回报"专项行动方案》。 2025年上半年，公司切实履行并持续评估《行动方案》的具体举措，现将 《行动方案》在报告期内的实施和效果评估情况报告如下： 一、聚焦主业，提升经营质效 2025年上半年，面对复杂多变的市场环境，公司始终坚持贯彻"以创新服 务人类健康"的经营理念，稳步推进公司长期战略。在医疗行业持续推进高质 量发展的大背景下，围绕技术和产品优势，以临床需求为导向，多种方式相结 合促进公司战略规划的顺利实施；以创新为第一动力，形成具有市场竞争力的 优质产能，着力为发展"新质生产力"蓄势赋能，推动技 ...

Group 1 - The core viewpoint of the news highlights the financial performance and trading activity of Kemei Diagnostics, indicating a decline in revenue and net profit for the first quarter of 2025 compared to the previous year [2] - As of August 26, Kemei Diagnostics experienced a financing net buy of -2.23 million yuan, with a total financing and securities balance of 206 million yuan, which is 5.86% of its market capitalization [1] - The company has a significant reliance on its LiCA series products, which account for 92.04% of its main business revenue [1] Group 2 - As of March 31, the number of shareholders for Kemei Diagnostics increased by 14.69% to 11,000, while the average circulating shares per person decreased by 12.81% to 36,384 shares [2] - For the first quarter of 2025, Kemei Diagnostics reported an operating income of 81.30 million yuan, a year-on-year decrease of 27.01%, and a net profit attributable to shareholders of 14.54 million yuan, down 62.12% year-on-year [2] - The company has distributed a total of 306 million yuan in dividends since its A-share listing, with 238 million yuan distributed over the past three years [3]

证券代码：688468 证券简称：科美诊断 科美诊断技术股份有限公司 二零二五年九月 三、 股东及股东代理人参加股东会依法享有发言权、质询权、表决权等 权利。股东及股东代理人参加股东会应认真履行其法定义务，不得侵犯公司和其 他股东及股东代理人的合法权益，不得扰乱股东会的正常秩序。 四、 股东及股东代理人要求在股东会现场会议上发言的，应于股东会召 开前一天向大会会务组进行登记。大会主持人根据会务组提供的名单和顺序安排 发言。 现场要求提问的股东及股东代理人，应当按照会议的议程举手示意，经会议 主持人许可后方可提问。有多名股东及股东代理人同时要求提问时，先举手者先 提问；不能确定先后时，由主持人指定提问者。 会议进行中只接受股东及股东代理人发言或提问。发言或提问应围绕本次会 议议题进行，简明扼要，时间不超过5分钟。发言或提问时需说明股东名称及所 持股份总数。每位股东及股东代理人发言或提问次数不超过2次。 科美诊断技术股份有限公司（688468） 2025年第一次临时股东会会议资料 五、 股东及股东代理人要求发言时，不得打断会议报告人的报告或其他 股东及股东代理人的发言。在股东会进行表决时，股东及股东代理人不再进行 ...